Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

NowPatient vs Ways2Well

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.1

NowPatient

Best for early adopters who want Foundayo via a one-stop telehealth platform

Starting at $199/mo

FoundayoTelehealthBrand Name
Visit NowPatient
7.1

Ways2Well

Best for patients wanting required-labs structure rather than questionnaire-only intake

Starting at $219/mo

CompoundedSemaglutideTirzepatideRequired labs
Visit Ways2Well

Side-by-Side Comparison

FeatureNowPatientWays2Well
Overall Score7.1/107.1/10
Starting Price$199/mo$219/mo
Customer Rating
Features3 features5 features
States Available5150
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

NowPatient

Pros

  • Confirmed early Foundayo channel (April 2026 rollout)
  • Daily oral pill — no needles, no refrigeration
  • Telehealth consultation included

Cons

  • Pricing tier not yet publicly verified — confirm directly with the provider
  • State-by-state availability still being phased in
  • Lower mean weight loss vs injectable GLP-1s (~11.1% vs 14.9% Wegovy and 20.9% Zepbound at labeled max)

Ways2Well

Pros

  • Required labwork enforces baseline monitoring
  • Both semaglutide and tirzepatide available
  • Clinician supervision through intake and follow-up

Cons

  • Pricing higher than aggressive compounded competitors
  • 3.0★ Trustpilot score lower than peers — review independent feedback before committing

Our Verdict

Both NowPatient and Ways2Well score equally well overall — the right choice depends on your priorities. Choose NowPatient if you want early adopters who want Foundayo via a one-stop telehealth platform, or Ways2Well if patients wanting required-labs structure rather than questionnaire-only intake matters most to you.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.